CN107898734B - Application of agave extract in preparing external itching-relieving and moisturizing personal care product - Google Patents
Application of agave extract in preparing external itching-relieving and moisturizing personal care product Download PDFInfo
- Publication number
- CN107898734B CN107898734B CN201810007426.8A CN201810007426A CN107898734B CN 107898734 B CN107898734 B CN 107898734B CN 201810007426 A CN201810007426 A CN 201810007426A CN 107898734 B CN107898734 B CN 107898734B
- Authority
- CN
- China
- Prior art keywords
- agave
- skin
- moisturizing
- extract
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 41
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 35
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 29
- 240000004246 Agave americana Species 0.000 title description 46
- 239000000203 mixture Substances 0.000 claims abstract description 65
- 244000193174 agave Species 0.000 claims abstract 6
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical group OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 17
- 239000000419 plant extract Substances 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 230000007803 itching Effects 0.000 abstract description 12
- 239000002537 cosmetic Substances 0.000 abstract description 9
- 238000002156 mixing Methods 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 44
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 13
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 11
- 229940035437 1,3-propanediol Drugs 0.000 description 11
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 11
- 239000004909 Moisturizer Substances 0.000 description 10
- 230000001139 anti-pruritic effect Effects 0.000 description 10
- -1 glucose ester Chemical class 0.000 description 10
- 230000001333 moisturizer Effects 0.000 description 10
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 230000000475 sunscreen effect Effects 0.000 description 6
- 239000000516 sunscreening agent Substances 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960005150 glycerol Drugs 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- 229940031723 1,2-octanediol Drugs 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 2
- 235000001619 Agave salmiana Nutrition 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- UMVMVEZHMZTUHD-UHFFFAOYSA-N DL-Propylene glycol dibenzoate Chemical compound C=1C=CC=CC=1C(=O)OC(C)COC(=O)C1=CC=CC=C1 UMVMVEZHMZTUHD-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010040799 Skin atrophy Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940100573 methylpropanediol Drugs 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000001797 sucrose acetate isobutyrate Substances 0.000 description 2
- UVGUPMLLGBCFEJ-SWTLDUCYSA-N sucrose acetate isobutyrate Chemical compound CC(C)C(=O)O[C@H]1[C@H](OC(=O)C(C)C)[C@@H](COC(=O)C(C)C)O[C@@]1(COC(C)=O)O[C@@H]1[C@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@H](OC(=O)C(C)C)[C@@H](COC(C)=O)O1 UVGUPMLLGBCFEJ-SWTLDUCYSA-N 0.000 description 2
- 235000010983 sucrose acetate isobutyrate Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229940074410 trehalose Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- KHICUSAUSRBPJT-UHFFFAOYSA-N 2-(2-octadecanoyloxypropanoyloxy)propanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C(O)=O KHICUSAUSRBPJT-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- AMUTYVGRCVFCCD-UHFFFAOYSA-N 5,6-diaminopyridine-3-carboxylic acid Chemical compound NC1=CC(C(O)=O)=CN=C1N AMUTYVGRCVFCCD-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- ZYMCJDAUBJFVSM-UHFFFAOYSA-N 6-methylheptyl 4-(dimethylamino)benzoate Chemical compound CC(C)CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 ZYMCJDAUBJFVSM-UHFFFAOYSA-N 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- BDMCAOBQLHJGBE-UHFFFAOYSA-N C60-polyprenol Natural products CC(=CCCC(=CCCC(=CCCC(=CCCC(=C/CCC(=C/CCC(=C/CCC(=C/CCC(=C/CCC(=C/CCC(=C/CCC(=C/CO)C)C)C)C)C)C)C)C)C)C)C)C BDMCAOBQLHJGBE-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 244000215562 Heliotropium arborescens Species 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OFSAUHSCHWRZKM-UHFFFAOYSA-N Padimate A Chemical compound CC(C)CCOC(=O)C1=CC=C(N(C)C)C=C1 OFSAUHSCHWRZKM-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229930186185 Polyprenol Natural products 0.000 description 1
- 229920001731 Polyprenol Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- IUWVALYLNVXWKX-UHFFFAOYSA-N butamben Chemical compound CCCCOC(=O)C1=CC=C(N)C=C1 IUWVALYLNVXWKX-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000010633 clary sage oil Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960001660 histamine phosphate Drugs 0.000 description 1
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical class CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 150000003096 polyprenols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000013529 tequila Nutrition 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 244000305618 wild century plant Species 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an application of a agave extract in preparing an external personal care product with itching relieving and moisture preserving functions. The composition obtained by mixing the agave extract and the second component achieves the effects of synergistic itching relieving and moisturizing. The agave extract and the composition of the agave extract and the second component can be used in personal care cosmetics and have the itching relieving and moisturizing effects which are safe, effective and easy to absorb.
Description
Technical Field
The invention belongs to the technical field of daily care products, and particularly relates to an application of a agave extract in preparing an external itching-relieving and moisturizing personal care product.
Background
The skin occupies the largest surface area of the body and acts as a protective layer for internal organs. Lack of proper skin care can lead to various skin problems such as dry skin, sagging, itching, roughness, spots, wrinkles, etc. These problems are caused by many reasons, such as environmental pollution, ultraviolet radiation, bacterial infection, skin sensitivity, and the like.
Under normal conditions, due to the water absorption effect and the barrier function of the stratum corneum and the covering effect of lipid substances secreted by sweat glands and sebaceous glands, water is not easy to lose, the stratum corneum can keep a certain water content, the water of the stratum corneum is increased and kept, and the skin can keep soft and keep elasticity. There are two main reasons for causing the stratum corneum to lack water and thus causing the skin to dry: firstly, the climate is dry and the relative humidity is low; secondly, the normal water absorption and barrier function of the skin are damaged, which becomes the cause of various skin diseases such as atopic dermatitis, so that the skin dryness is a considerable problem. Moisturizers in cosmetics mainly include the following categories: polyhydric alcohol moisturizers, hyaluronic acid moisturizers, lactic acid and sodium lactate, sodium pyrrolidone carboxylate, ceramide moisturizers, amide moisturizers, glucose ester moisturizers, collagen moisturizers, chitin derivatives, chitosan and the like. They have drawbacks in some respects, such as: although glycerin, which is a polyhydric alcohol, absorbs moisture in the air to achieve a moisturizing effect, glycerin cannot form a protective film and has a deep moisturizing effect. The moisturizing effect of the hyaluronic acid solution is that a viscoelastic film is formed, which has a strong water-retaining property (as does hyaluronic acid in intercellular matrix of skin connective tissue), is completely transparent, does not leave marks and greasy feeling, and has a soft, smooth and lubricious feeling, but it cannot penetrate the horny layer of epidermis (even short chain hyaluronic acid degradation products of 5 to 10 disaccharide units do not easily pass through the horny layer of epidermis).
Pruritus is a common complication of sensitive skin, and cosmetics are mostly used in modern society regardless of men and women, old and young, but can induce skin irritation, inflammation, allergy, pruritus and the like.
Many substances causing skin itching are known, such as histamine, substance P, bradykinin, protease, prostaglandin, and morpholinopeptide, but it is a field in which research is progressing slowly because quantitative and objective evaluation is difficult.
The treatment of cutaneous pruritus is on the one hand based on drugs, but more importantly the patient is careful to care for the skin, overcoming scratching, which leads to a vicious circle of more and more itching, with further aggravation of the symptoms.
For the treatment of itching, antihistamines and antiallergic agents have been used as internal agents, while antihistamines, adrenocortical steroid agents, non-steroidal anti-inflammatory agents, camphor, menthol, phenol, salicylic acid, tar, crotamiton, capsaicin, or moisturizers (urea, heliotrope, vaseline, etc.) have been used as external agents. However, when the oral preparation is used, problems such as a certain period of time required for clinical effects, side effects (sleepiness and lassitude) on the central nervous system, and damage to the digestive system may occur. On the other hand, when the external preparation is used, the antipruritic effect is insufficient, and particularly when the steroid preparation is used for a long period of time, there are problems of general reactions such as decrease in adrenal function, rebound, skin atrophy, steroid purpura, skin atrophy spots, steroid acne and other local side effects.
The development trend of cosmetics in the world at present advocates green, natural, safe and environment-friendly cosmetics with certain efficacy. More and more consumers are looking for cosmetic manufacturers to develop more natural, effective skin care products to make the skin healthier. Therefore, the development of natural, mild and practical cosmetic ingredients has become essential for the development of new cosmetic products.
Agave is a plant produced in the semi-desert area of the volcanic plain with an altitude of 2500 m in mexico, and comprises several species of blue Agave (Agave tequila), black Agave (Agave salmina), green Agave, gray Agave, spiny Agave and rainbow Agave. The agave succus is rich in polysaccharide, and is often used for fermentation and brewing wine, and the agave wine has effects of reducing weight, promoting digestion, resisting osteoporosis, preventing type 2 diabetes, reducing senile dementia, improving sleep, etc.
The use of agave syrup as a skin moisturizing ingredient is described in chinese patent CN 102316848B; the anti-inflammatory effect of aqueous extracts of agave on mice is also described in the non-patent literature (Shuleya, et al, university of North China (Nature), 2(5):377-379 (2001)). In addition, the researchers of the project do not find the report of the agave extract and the composition as the skin external preparation in the aspects of relieving itching and moisturizing the skin.
Disclosure of Invention
In view of the above-mentioned blank in the art, the present invention provides a agave extract composition having antipruritic and moisturizing effects that can be used in cosmetics safely, effectively and easily absorbed.
A plant extract composition characterized by: comprises agave extract and a second component: one or more of glycerol, 1, 3-propanediol, 1, 2-propanediol, 1, 3-butanediol, 1, 2-pentanediol, methylpropanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol, 1, 5-pentanediol, 1, 6-hexanediol, 1, 8-octanediol and 1, 2-decanediol, wherein the weight ratio of the agave stem extract to the second component is 1:99 to 99: 1.
The second component is selected from: one or more of glycerol, 1, 3-propanediol, 1, 2-propanediol, 1, 3-butanediol and 1, 2-pentanediol, wherein the weight ratio of the agave extract to the second component is 30:70 to 70: 30.
The second component is 1, 3-propylene glycol, and the weight ratio of the agave extract to the second component is 60: 40.
A personal care product comprises an effective amount of the plant extract composition.
Preferably: contains 0.01 to 99 weight percent of plant extract composition.
Wherein the content of the plant extract composition is 1% to 20%.
Wherein the content of the plant extract composition is 10%.
The application of the agave extract or the plant extract composition in preparing the personal care product for external use and relieving itching and moisturizing.
The care product is a personal skin care product and a personal washing product.
According to the present invention, the term "agave extract" refers to an extract containing an active ingredient extracted from agave by any suitable means.
In the invention, the agave extract can generate obvious skin itching relieving and moisturizing effects. Meanwhile, the second component can generate a synergistic effect so as to improve the itching relieving and moisturizing effects of the composition. For example, the two compositions produce an effect that exceeds the effect expected of the agave extract and the second component when used alone.
The second component contained in the agave extract composition is one or more of glycerol, 1, 3-propanediol, 1, 2-propanediol, 1, 3-butanediol, sorbitol, 1, 2-pentanediol, methylpropanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol, 1, 5-pentanediol, 1, 6-hexanediol, 1, 8-octanediol, and 1, 2-decanediol. Preferably, the second component is selected from: one or more of glycerol, 1, 3-propylene glycol, 1, 2-propylene glycol, 1, 3-butanediol and 1, 2-pentanediol. In embodiments provided herein, the second component is optimally selected from: 1, 3-propanediol.
In the agave extract composition, the ratio of the agave extract to the second component is 1:99 to 99: 1. Preferably, the ratio of agave extract to the second component is from 30:70 to 70: 30. In embodiments provided herein, the second component is 1, 3-propanediol, preferably in a 60:40 ratio.
Another embodiment of the present invention relates to a personal skin care composition or a personal cleansing composition, which is appropriately selected depending on the usage, dosage form, age, sex, symptom, itching, dryness and the like of a subject to be administered, and which comprises 0.01 to 99% of the plant extract composition according to claim 1, wherein when the amount to be mixed is less than 0.01% based on the total amount of the composition, the effect of the present invention cannot be exerted, and no improvement in the effect is observed even when the amount exceeds 99%. Preferably, the agave extract composition is added in an amount of 1% to 20% in the personal care composition or the cleansing composition. In an embodiment provided herein, the optimal amount of agave extract composition added is 10%.
The personal skin care compositions or personal cleansing compositions described herein may be those described elsewhere in this specification or known to those of skill in the art. Non-limiting examples of products include moisturizers, moisturizing creams, sunscreens, lotions, foundations, night creams, shampoos, body washes, facial masks. Furthermore, the personal skin care composition or personal cleansing composition may be formulated as a leave-on or rinse-off product. These forms of personal skin care compositions and personal cleansing compositions can be prepared by methods well known to those skilled in the art.
The personal skin care compositions or personal cleansing compositions of the present invention may include other beneficial agents and compounds such as oils, waxes, sunscreens, moisturizers, antioxidants, emulsifiers, preservatives, thickeners and the like.
Non-limiting oils that may be used in combination with the compositions of the present invention include: phytosterol isostearate, neopentyl glycol diheptanoate, hydrogenated coconut oil glycerides, hydrogenated methyl rosinate, hydrogenated polyprenol, caprylic/capric triglyceride, ethyl hexanol palmitate, sucrose acetate isobutyrate, butyl stearate, propylene glycol dibenzoate, polymethylsiloxane, octyldodecanol, isoparaffin, petrolatum, isooctyl palmitate, vegetable lanolin, castor oil, hydrogenated castor oil, lecithin, hydrogenated lecithin, evening primrose oil, sweet almond oil, wheat germ oil, avocado oil, grape seed oil, jojoba oil, calendula oil, rapeseed oil, lavender oil, chamomile oil, clary sage oil, sunflower seed oil, cocoa butter, corn oil, peppermint oil, coconut oil caprylate/caprate, cholesterol hydroxystearate, propylene glycol dicaprylate/dicaprate, glycerin, hydrogenated palm oil/capric triglyceride, ethyl hexanoate, sucrose acetate isobutyrate, butyl stearate, propylene glycol dibenzoate, methyl palmitate, hydrogenated polydecamomile, hydrogenated polysufol, hydrogenated palm oil/capric acid triglyceride, hydrogenated castor oil, hydrogenated lecithin, hydrogenated soybean oil, hydrogenated, Rice bran oil, rosemary oil, sage oil and squalane.
Non-limiting waxes that may be used in combination with the compositions of the present invention include: natural beeswax, synthetic beeswax, sugar cane wax, candelilla wax, carnauba wax, ozokerite, paraffin wax.
Non-limiting sunscreens which may be used in combination with the compositions of the present invention include chemical and physical sunscreens. Non-limiting examples of chemical sunscreens that may be used include: benzophenone-3, benzophenone-4, ethylhexyl salicylate, ethylhexyl methoxycinnamate, butyl methoxydibenzoylmethane, octocrylene, ethylhexyl triazone, isoamyl p-dimethylaminobenzoate, isooctyl p-dimethylaminobenzoate, butyl p-aminobenzoate. Non-limiting examples of physical sunscreens that may be used include: zinc oxide, titanium dioxide.
Non-limiting examples of humectants that can be used in combination with the compositions of the present invention include: sodium hyaluronate, trehalose, erythritol, glycosyl trehalose/hydrogenated starch hydrolysate, biogan-1, hydrolyzed corn starch, acetyl chitosamine, Aureobasidium pullulans, oat beta-glucan, sodium polyglutamate, pyrrolidone carboxylate, and Aloe barbadensis extract.
Non-limiting examples of antioxidants that can be used in combination with the compositions of the present invention include: 3-o-ethyl ascorbic acid, ascorbyl palmitate, superoxide dismutase, BHA, BHT, grape seed extract, green tea extract, sodium metabisulfite, tocopherol, tocopheryl acetate.
In some aspects of the invention, the composition does not include an emulsifier. However, in other aspects, the composition includes one or more emulsifiers. Emulsifiers, which may be nonionic, cationic, anionic and zwitterionic emulsifiers, are capable of reducing interfacial tension between phases and improving the stability of the formulation. Non-limiting examples include: sucrose stearate, sodium stearyl lactylate, polyethylene glycol fatty acid esters, sorbitan anhydride esters, polyoxyethylene fatty ether phosphate, TEA stearate, and mixtures thereof.
Non-limiting examples of preservatives that may be used in combination with the compositions of the present invention include: p-hydroxyacetophenone, phenoxyethanol, parabens, sorbic acid, triclosan, chlorhexidine and other classes of compounds listed in cosmetic hygiene specifications.
Non-limiting examples of thickeners that may be used in combination with the compositions of the present invention include: sodium polyacrylate/C13-14 isoparaffin/trideceth-6, polyacrylic acid, xanthan gum, carboxymethylcellulose, hydroxyethylcellulose, polyethylene glycol mono-and diesters, fatty alcohol ethoxylates.
Experiments show that the maguey extract which is naturally extracted or the maguey extract which is matched with the second composition has the effects of obviously improving the skin pruritus and moisturizing.
Drawings
FIG. 1 shows the antipruritic effect of the Agave extract and different second components,
figure 2 moisturizing effect of agave extract and different second components,
FIG. 3 shows the antipruritic effect of 1, 3-propanediol with different contents,
FIG. 4 shows the moisturizing effect of different amounts of 1, 3-propanediol,
figure 5 antipruritic effect of different amounts of the composition in personal skin care,
figure 6 moisturizing effect of different amounts of compositions in personal skin care,
figure 7 shows the antipruritic effect of different amounts of the composition in the personal cleansing product,
figure 8 moisturizing effect of different amounts of the composition in the personal cleansing product.
Detailed Description
Hereinafter, preferred embodiments and comparative examples are disclosed for the understanding of the present invention. However, the following examples are provided for easier understanding of the present invention, and the scope of the present invention is not limited to the following examples.
The efficacy of the compositions of the present invention can be determined by methods known to those of ordinary skill in the art. The following are non-limiting embodiments that can be used in the present invention. It will be appreciated that other verification schemes may be used, including, for example, objective and subjective schemes.
Examples 1 to 5 and comparative examples 1 to 6
In this example, the selection of the second component of the agave extract and composition of the present invention, the activity of which in suppressing skin itch and moisturizing, was confirmed by the following assay.
Test for antipruritic Effect
Guinea pigs were then divided into 2 groups of 10 animals each, and the control group was combined with the examples. One day prior to the experiment, the right hind instep of each group of guinea pigs was painted with a sample. On the day of experiment, the shaved part of the right hind paw of the animal was abraded with coarse sandpaper to about 1cm2And the sample is smeared at the position once. After 10min, 0.01% histamine phosphate 0.5 mL/body is dripped on the wound surface, and the concentration is increased by 0.01%, 0.02%, 0.03%, 0.04%. the.
Test of moisturizing Effect
Skin moisture content was measured using a Nova Dermal Phase Meter skin moisture tester. The instrument reflects changes in skin moisture content by measuring skin impedance: the outer layer of skin has different electrical properties and conducts electricity poorly when the skin is dry. As its moisture content increases, the conductivity increases and, as a result, the skin impedance changes (related to conductivity) and can be used to assess changes in skin hydration.
10 subjects with moderately dry skin were selected, with an average age of 32.8 years, and within the washout period of 1 week prior to the test, were asked to have a normal bath, but not to have any moisturizing product applied to the forearms of both hands after bathing. Smearing test samples on the forearm test parts of both hands of a subject in the morning and evening after the start of the experimentThe coating amount is 2mg/cm2And (4) calculating. And measuring the stratum corneum moisture growth rate of the tested part of the tested subject by adopting a skin moisture tester at 2 weeks.
As shown in fig. 1 to 2, it can be seen from the test results that the agave extract has the effect of improving skin itch and moisturizing, and has the best effect on improving skin itch and moisturizing when the second component is 1, 3-propanediol.
Examples 7 to 11
Composition (I) | Example 7 | Example 8 | Example 9 | Example 10 | Example 11 |
Agave extract (%) | 70 | 60 | 50 | 40 | 30 |
1, 3-propanediol (%) | 30 | 40 | 50 | 60 | 70 |
In this example, it was confirmed that the optimum ratio of the agave extract to the second component 1, 3-propanediol in the agave extract composition of the present invention was improved in skin itch and moisturizing effect by the following analysis.
Examples 7 to 11 antipruritic effects (test methods same as above)
Examples 7 to 11 moisturizing effect (test methods same as above)
As shown in fig. 3 to 4, it can be seen from the test results that the ratio of agave extract to 1, 3-propanediol is 60:40, which has the best effect on the improvement aspect of skin itch and moisturizing property.
Examples 12-15 personal skin Care compositions
Preparation of personal skin care compositions: add the ingredients of phase a to the beaker and heat to 70-75 ℃ while mixing. Subsequently, the ingredients of phase B were heated to 70-75 ℃ while mixing. Slowly pouring the phase B into the phase A, and homogenizing. Cooling the mixture to 40 ℃, slowly adding the phase C and the phase D under the stirring state, and uniformly stirring.
Examples 12 to 15 antipruritic effect test (test methods same as above)
Examples 12 to 15 test for moisturizing Effect (test methods same as above)
As shown in fig. 5 to 6, it can be seen from the test results that the agave extract composition has the best effect on the improvement of skin itch and moisturizing property at the addition ratio of 10% in the personal care products.
Examples 16-19 personal cleansing compositions
Preparation of personal cleansing composition: heating the component A to about 85 deg.C until it is completely dissolved, adding the component B, stirring, cooling to about 55 deg.C, adding the component C, stirring, adding the component D, and stirring.
Examples 16 to 19 test for antipruritic effect (the same test methods as above)
Examples 16 to 19 test for moisturizing Effect (test methods same as above)
As shown in fig. 4, it can be seen from the test results that the agave extract composition has the best effect on the improvement of skin itch and moisturizing property at the addition ratio of 10% in the personal cleansing composition.
The agave extract composition has good effects of improving skin itch and moisturizing, and is effective in treating skin itch and moisturizing. The agave extract composition of the present invention can be easily formulated into personal skin care products and personal cleansing compositions for daily use by mixing various materials as other ingredients than the active ingredient.
Claims (5)
1. The application of the plant extract composition in preparing the external itching-relieving and moisturizing care product comprises the agave extract and a second component, wherein the second component is 1, 3-propylene glycol, and the weight ratio of the agave extract to the second component is 60: 40.
2. Use according to claim 1, the care products being personal skin care products and personal washing products.
3. The use according to claim 2, wherein the skin care product is a personal skin care product comprising from 0.01% to 99% by weight of the plant extract composition.
4. Use according to claim 3, wherein the content of the plant extract composition is between 1% and 20%.
5. The use according to claim 4, wherein the plant extract composition is present in an amount of 10%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810007426.8A CN107898734B (en) | 2018-01-04 | 2018-01-04 | Application of agave extract in preparing external itching-relieving and moisturizing personal care product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810007426.8A CN107898734B (en) | 2018-01-04 | 2018-01-04 | Application of agave extract in preparing external itching-relieving and moisturizing personal care product |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107898734A CN107898734A (en) | 2018-04-13 |
CN107898734B true CN107898734B (en) | 2021-08-31 |
Family
ID=61872268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810007426.8A Active CN107898734B (en) | 2018-01-04 | 2018-01-04 | Application of agave extract in preparing external itching-relieving and moisturizing personal care product |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107898734B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108703892B (en) * | 2018-07-27 | 2021-05-11 | 广州汇朗生物科技有限公司 | New application of 1, 5-pentanediol |
CN110269818A (en) * | 2019-05-14 | 2019-09-24 | 广州辰美化妆品有限公司 | Composition for skin care item |
CN112089827A (en) * | 2020-10-30 | 2020-12-18 | 湖南婕妙生物科技有限公司 | Prebiotic-containing pharmaceutical composition for regulating female vaginal microecological balance, preparation and use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104546606A (en) * | 2014-12-26 | 2015-04-29 | 青蛙王子(中国)日化有限公司 | Oil-in-water stretch marks remover and preparation method thereof |
CN105078830A (en) * | 2015-08-27 | 2015-11-25 | 华南理工大学 | Natural preservative children plant sunscreen lotion and preparation method thereof |
CN106511221A (en) * | 2017-01-04 | 2017-03-22 | 广州聚澜健康产业研究院有限公司 | Acne-removing facial cleanser |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2551972B1 (en) * | 1983-09-21 | 1986-05-16 | Bouzid Moussaad | Anti-dandruff and anti-hair loss |
CN105055253B (en) * | 2015-08-29 | 2018-02-23 | 广州煜明生物科技有限公司 | A kind of natural moisture preserving composition and preparation method thereof and the application in cosmetics |
CN105380857B (en) * | 2015-12-07 | 2018-06-22 | 青蛙王子(中国)日化有限公司 | A kind of long-acting children's mosquito-repellent paste and preparation method thereof |
-
2018
- 2018-01-04 CN CN201810007426.8A patent/CN107898734B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104546606A (en) * | 2014-12-26 | 2015-04-29 | 青蛙王子(中国)日化有限公司 | Oil-in-water stretch marks remover and preparation method thereof |
CN105078830A (en) * | 2015-08-27 | 2015-11-25 | 华南理工大学 | Natural preservative children plant sunscreen lotion and preparation method thereof |
CN106511221A (en) * | 2017-01-04 | 2017-03-22 | 广州聚澜健康产业研究院有限公司 | Acne-removing facial cleanser |
Also Published As
Publication number | Publication date |
---|---|
CN107898734A (en) | 2018-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11679284B2 (en) | Skin care formulations | |
CN103237555B (en) | Topical skin care formulation | |
US20180021247A1 (en) | Topical compositions comprising hydroxy acids and cannabinoids for skin care | |
EP3520796A1 (en) | Composition containing water-solubilized ursodeoxycholic acid for preventing or treating inflammatory skin disease or serious pruritus | |
AU727993B2 (en) | Topical composition and method for enhancing lipid barrier synthesis | |
TW200526260A (en) | Cosmetic composition and methods | |
WO2017100873A1 (en) | Cosmetic composition and use thereof | |
CN111557886B (en) | Plant-nourishing efficient moisturizing cream and preparation method thereof | |
CN107898734B (en) | Application of agave extract in preparing external itching-relieving and moisturizing personal care product | |
US20220378690A1 (en) | Compositions and methods for treating skin | |
WO2018075810A1 (en) | Dermatological compositions for providing nutrients to skin and methods thereof | |
US20210100725A1 (en) | Topical formulations comprising strontium and methylsulfonylmethane (msm) and methods of treatment | |
JP2009161564A (en) | Therapeutic composition for atopic dermatitis | |
KR100904200B1 (en) | Cosmetic composition for skin moisturizing containing honey leaf extract and aloe vera extract | |
Schölermann et al. | Efficacy and safety of Eucerin 10% urea lotion in the treatment of symptoms of aged skin | |
CN109453088B (en) | Whitening and firming cream, preparation method thereof and tyrosinase inhibitor | |
Tadini et al. | In vivo skin effects of a dimethylaminoethanol (DMAE) based formulation | |
WO2018198039A1 (en) | Topical skin care compositions | |
EP3490577B1 (en) | Skin compositions comprising turmerones | |
CN114949056A (en) | Herbal maintenance cream | |
Kwangsukstid et al. | Comparative Clinical Evaluation of Centotheca lappacea Extract Cream for Skin Lightening and Tightening Effects in Asian Women: A Randomized, Double-Blind, Controlled Study. | |
CN119564555A (en) | A repair composition and its preparation method and repair preparation | |
KR20230143023A (en) | Composition for improving skin comprising Sizigium formosium extract as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |